
Finless Foods
Good for us. Good for the ocean.
Emeryville, United States · Founded 2017 · $37.5M raised
- Headquarters
- Emeryville, California
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2C
- Website
- finlessfoods.com
- Total Funding
- $37.5M
- Last Round
- $34.0M Convertible NoteApr 2024
- Rounds
- 5
About
Finless Foods is a biotechnology company developing cell-cultured and plant-based seafood alternatives, with an initial focus on bluefin tuna. Co-founded in 2017 by Michael Selden and Brian Wyrwas, the company uses proprietary cell lines and bioprocess technology to grow fish meat outside of a living fish, offering consumers delicious, healthy, and sustainable seafood options without the environmental cost of wild fishing. Finless Foods aims to reduce pressure on global fish stocks — starting with tuna, the world's most consumed fish — by bringing cell-cultured seafood products to market at scale.
Summary
Finless Foods is a Biotech company based in Emeryville, United States, founded in 2017. It has raised $37.5M in total across 5 rounds, most recently a $34.0M Convertible Note round in Apr 2024. Investors include Draper Associates, Hanwha Solutions and Olive Tree Capital.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2024
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Draper Associates
2 rounds
Hanwha Solutions
1 round
Olive Tree Capital
2 rounds
Dainichi Corp
1 round
At One Ventures
1 round

Justin Kan (Twitch founder)
1 round

Humboldt Fund
1 round

Gaingels
1 round
Sustainable Ocean Alliance
1 round
SOSV
1 round
Softmatter VC
1 round
Starlight Venture Capital
1 round
The U-Start Club
1 round

Blue Horizon Ventures
1 round

Hemisphere Ventures
1 round
Babel Ventures
1 round
Yakumi Investment
1 round

Harrison Blue Ventures
1 round
Similar Companies
Decarbonizing the chemicals industry.
Leading North American energy infrastructure platform.
Self-driving cars.
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...